Stock listing

Maat Pharma

Selected listing: MAAT · EURONEXT · EUR · FR

Maat Pharma (Euronext:MAAT), Health Technology. Latest release Sep 29, 2026: MaaT Pharma Publishes its Half-Year 2026 Results and Provides a Business Update.

MAAT:EURONEXTEURFRUpdated October 3, 2026

Ticker: Euronext:MAAT
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Euronext
Currency: EUR

About Maat Pharma

Maat Pharma is a public company traded under the ticker MAAT on the French market. Maat Pharma focuses on developing innovative therapies in the pharmaceutical sector.

Latest news from Maat Pharma

MaaT Pharma Publishes its Half-Year 2026 Results and Provides a Business Update

September 29, 2026

MaaT Pharma publie ses résultats semestriels 2026 et fait le point sur ses activités

September 28, 2026

MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors

September 21, 2026

MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination

September 18, 2026

MaaT Pharma Receives Negative CHMP Trend Vote for MaaT013 (Xervyteg®) Following Re-Examination for its Conditional Marketing Authorization Application in Europe

September 15, 2026

All Maat Pharma news →

Research Maat Pharma

Maat Pharma company profile

View the public company page for Maat Pharma on 6ix.

Maat Pharma news

Read company news and market updates connected to Maat Pharma.

Maat Pharma investor events

Find investor webinars, events, and replay context for Maat Pharma.